Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. - Wikidata - wikimedia - TriplyDB

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.

http://www.wikidata.org/entity/Q36353974

about

Mesenchymal stem cells avoid allogeneic rejection Theiler's virus infection: a model for multiple sclerosis Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria Combining cytotoxic and immune-mediated gene therapy to treat brain tumors Production of TGF-beta1 as a Mechanism for Defective Antigen-presenting Cell Function of Macrophages Generated in vitro with M-CSF.Advances in cancer vaccine development.Transforming growth factor beta (TGF-beta) and inflammation in cancer.TGF-beta and regulatory T cell in immunity and autoimmunity Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains.Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.Murine and bovine γδ T cells enhance innate immunity against Brucella abortus infections.Role of TNF in lymphocyte-mediated cytotoxicity.The transforming growth factor-betas. A new family of immunoregulatory molecules.Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system.Role of TGF-beta in immune-evasion of cancer.MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo.Transforming growth factor beta 1 and gamma interferon provide opposing signals to lipopolysaccharide-activated mouse macrophages.Mechanisms of malignant glioma immune resistance and sources of immunosuppression Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma.Transforming growth factor-beta as a regulator of site-specific T-cell inflammatory response.Induction of transforming growth factor beta 1 by purified protein derivative of Mycobacterium tuberculosis.Transforming growth factor beta is protective in host resistance against Listeria monocytogenes infection in mice Production of the immunosuppressive cytokine interleukin-10 by Epstein-Barr-virus-expressing pyothorax-associated lymphoma: possible role in the development of overt lymphoma in immunocompetent hosts Cold ischemia induces isograft arteriopathy, but does not augment allograft arteriopathy in non-immunosuppressed hosts Transforming growth factor-beta in human cutaneous leishmaniasis Transforming growth factor-beta and suppression of humoral immune responses in HIV infection.Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease.Gene therapy of liver diseases.Cellular and functional characterization of immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes reveals their up-regulated synthesis of biologically active TGF-beta.Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors Update on the immunological pathway of negative regulation in acute insults and sepsis Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo.Immunotherapy of malignant brain tumors.CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer In vivo activity of tumor necrosis factor (TNF) mutants. Secretory but not membrane-bound TNF mediates the regression of retrovirally transduced murine tumor Immunotherapy for malignant glioma: current approaches and future directions.Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia.A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus

P2860

Q21245658-47B0DAE7-9913-495A-BD03-EEDF3401A060 Q24629115-A7262555-C5BB-4AB6-86BF-AB3B0B629BBB Q28202655-3B3825EA-7F93-42C1-B8C5-9959ED83368F Q28730618-80BC982B-6E26-4C2F-B17E-024241A81067 Q31013320-29229F7A-8E6A-499C-9B26-EBEFA89443F9 Q33578067-BA91CA24-89CC-4691-9E6D-C31C1BC615A6 Q33603404-C63AF802-5E97-4A34-B9DB-7650C9EC0BC3 Q33712568-027BB8C1-93B6-4EBC-88F0-E6D1CDC77752 Q33722462-65800935-9986-4959-8849-F1AEF72ED051 Q33753916-0DCF1AB4-78C3-4412-8F56-5EBDB86FA790 Q33857573-DEFA8FB7-9BB4-4D34-BA6D-9D60A31105A7 Q33963886-5A28074D-6464-420C-A44F-323B55313C16 Q33966313-DEB4DFA5-9548-4DD8-A1F9-562F3D868D90 Q34042442-93D35550-4FDE-4B49-815F-7665131E2464 Q34071322-92FE4FB0-B9AA-4E32-80A9-BF998B957032 Q34136492-6CBF18A1-AD1C-4CE8-859F-18CFC5E13ACE Q34509937-8DDFF785-5E8F-4C67-AB29-F2BB2F110BDD Q34535717-2ED1ECDD-4FC8-45B6-870D-D54062AE2F5D Q34661793-550FAEC9-5C6C-435D-8279-B0600F83F9E0 Q35113661-FD85807F-1E67-4F9D-8FE3-F64043A797DF Q35180160-AE50BD3E-B6A2-43A4-B63D-92ADA508DD50 Q35379930-CBD45DDF-4A04-4644-950C-7ADD814C1B09 Q35520360-A8356BF7-5BB3-43D0-8E48-F72DAA65A992 Q35765267-4339C02D-B304-4E67-B189-5ED598151201 Q35788816-94D4762D-1FEC-4FA6-A707-67058C896D8B Q35798613-CB76D1CD-0450-4FD3-8301-52AC0F58B924 Q35820173-82915675-D20C-414F-ACFA-A1F480A40B87 Q35832573-E06D4BA7-5D81-4DE4-862C-11BBEBFE9914 Q35842662-DCE701CF-3C5E-4C74-8140-AF821AB490D8 Q35847139-EDEFC59A-6E47-4612-BB7A-CD4BB21CF360 Q35945218-1BE9FFA6-9D26-4589-8D47-878600CF9986 Q36079845-85456112-AF3A-435B-BA4F-8A7F89CF995D Q36080342-7F3E7667-0357-46AC-B66A-BC8400FA41D8 Q36094915-8EAE5BED-CFCA-4826-B483-EA0AC641A34E Q36162929-9B349BDA-F052-497E-A916-0A712116F4C4 Q36235825-EF6E9705-4B9D-4AA0-8BAF-EB9FB5059298 Q36238339-5DB12C13-B18C-4B62-97B9-9FFD2277C4AF Q36273693-3D1D650E-7EE4-46EF-8EC9-F59998F77BD4 Q36352081-C9934BF4-02A8-4C88-A34D-90AB8EAA378B Q36353817-D241CC98-CE49-4CD1-9B47-81E972102863

P2860

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.

http://www.wikidata.org/entity/Q36353974

description

1987 nî lūn-bûn

@nan

1987年の論文

@ja

1987年学术文章

@wuu

1987年学术文章

@zh-cn

1987年学术文章

@zh-hans

1987年学术文章

@zh-my

1987年学术文章

@zh-sg

1987年學術文章

@yue

1987年學術文章

@zh

1987年學術文章

@zh-hant

name

Inhibition of cytotoxic T cell ...... t tumor necrosis factor alpha.

@ast

Inhibition of cytotoxic T cell ...... t tumor necrosis factor alpha.

@en

type

label

Inhibition of cytotoxic T cell ...... t tumor necrosis factor alpha.

@ast

Inhibition of cytotoxic T cell ...... t tumor necrosis factor alpha.

@en

prefLabel

Inhibition of cytotoxic T cell ...... t tumor necrosis factor alpha.

@ast

Inhibition of cytotoxic T cell ...... t tumor necrosis factor alpha.

@en

P1433

Q36353974-F17DB3F8-C27C-4B56-8801-55B730D02D90

P1476

Q36353974-5A293D30-FEB4-4F07-808C-0636D67BA313

P2093

Q36353974-0F9980A1-FD4E-49BA-B098-CDC3CEBCF298

Q36353974-2CD8147E-7CEF-4140-ACF3-A422577CF652

Q36353974-7FC6EFC0-DB2B-45B1-8B0C-089F8CBC28BD

P2860

Q36353974-02B2B0A0-5B07-4E03-9B2D-BE08BE30C63C

Q36353974-16EF79C6-E4AA-454E-B277-6387EB9946E2

Q36353974-1FBCB4C7-EA56-4910-B8FB-C222A6AB8E50

Q36353974-381B9CCB-E3E9-4BD0-855C-5B0DD45124AE

Q36353974-3B2B0C73-8AD1-49ED-9F37-445B09842981

Q36353974-3DD60D0A-45BA-469C-99F6-47506752DA9B

Q36353974-7C3407EE-48B8-455D-86E8-B7C955F789B5

Q36353974-80B85334-14F5-4F3A-8442-1CA443EA0992

Q36353974-AF2F4141-A761-4FD7-97F5-2A28E5EF8037

Q36353974-ED1CCCDE-7C44-40BC-81DD-55C26CC37317

P304

Q36353974-F11C4386-2002-4784-8821-D869047B56FA

P31

Q36353974-0F4BAD11-7BC2-4D8A-9B5E-A51FD6F52063

P356

Q36353974-928F2ED8-39F1-4547-91D6-63B7D6D82433

P407

Q36353974-B89ABC66-E626-4ECA-8D3A-C021331BB8F5

P433

Q36353974-227F5D65-4B5E-4BAC-A5B5-BEB682B7B00D

P478

Q36353974-977C9255-21C3-4FF2-AF09-5290F04A5948

P50

Q36353974-9713AD12-6035-4A83-9695-97E8DE7B74C0

P577

Q36353974-AA4A86DB-547D-4579-88B6-3AD673451E77

P5875

Q36353974-57AFD88E-1EB9-4CB1-9F0B-2056C24F41DB

P698

Q36353974-551A5BEC-94B2-445C-8592-5D7AEFAF5E29

P921

Q36353974-9B2FD234-4392-4DC8-9FFA-FE5E826060FA

P932

Q36353974-01B8B0EA-6C37-4B6F-85CD-17E1DD9C1C68

P356

P1433

Journal of Experimental Medicine

P1476

Inhibition of cytotoxic T cell ...... t tumor necrosis factor alpha.

@en

P2093

Figari IS

http://www.w3.org/2001/XMLSchema#string

Palladino MA Jr

http://www.w3.org/2001/XMLSchema#string

Ranges GE

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity

Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

Sequence of the porcine transforming growth factor-beta precursor.

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.

BSC-1 growth inhibitor/type beta transforming growth factor is a strong inhibitor of thymocyte proliferation.

Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.

Synergy between recombinant interleukin 2 (rIL 2) and IL 2-depleted lymphokine-containing supernatants in facilitating allogeneic human cytolytic T lymphocyte responses in vitro.

A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

P304

991-998

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.166.4.991

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P50

P577

1987-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277425792

http://www.w3.org/2001/XMLSchema#string

P698

3498791

http://www.w3.org/2001/XMLSchema#string

P921

P932

2188710

http://www.w3.org/2001/XMLSchema#string